The core market drivers—the growing global incidence of bladder cancer, particularly among the aging population, and the success of novel biologic therapies—are expected to sustain the 4.7% CAGR predicted by some analysts. The market is increasingly focused on developing effective, bladder-sparing treatments for NMIBC to address the ongoing challenge of high recurrence rates and drug ... https://www.databridgemarketresearch.com/reports/global-bladder-cancer-treatment-market